Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAkman\\-Demir, Gulsen
dc.contributor.authorTuzun, Erdem
dc.contributor.authorWaters, Patrick
dc.contributor.authorIcoz, Sema
dc.contributor.authorKurtuncu, Murat
dc.contributor.authorJarius, Sven
dc.contributor.authorYapici, Zuhal
dc.contributor.authorMutlu, Melike
dc.contributor.authorYesilot, Nilufer
dc.contributor.authorVincent, Angela
dc.contributor.authorEraksoy, Mefkure
dc.date.accessioned2025-10-16T15:37:57Z
dc.date.issued2011
dc.identifier.doi10.1007/s00415-010-5780-4
dc.identifier.otherWOS:000287924200016
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9737
dc.publisherSPRINGER HEIDELBERG
dc.sourceJOURNAL OF NEUROLOGY
dc.subjectNeuromyelitis optica
dc.subjectMultiple sclerosis
dc.subjectNMO\\-IgG
dc.subjectAnti aquaporin\\-4 antibodies
dc.subjectAquaporin\\-4 seropositivity
dc.subjectPrognosis
dc.titlePrognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS